PDCD1 and breast carcinoma: Notably, melanoma-associated antigen-A11 (MAGE-A11)-specific CTLs, when combined with a Tim-3 and PD-1 blockade, demonstrated significantly amplified cytotoxic effects against breast cancer cells [41].